ProAssurance Corporation (NYSE:PRA) Files An 8-K Regulation FD Disclosure

0
ProAssurance Corporation (NYSE:PRA) Files An 8-K Regulation FD Disclosure

ProAssurance Corporation (NYSE:PRA) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure

In this Current Report on Form 8-K we are furnishing materials which we will using during meetings and presentations starting on June 11, 2019. These materials are presented in Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

99.1 Materials which we will begin using during meetings and presentations starting June 11, 2019.

We are furnishing Exhibit 99.1 to this Current Report on Form 8-K in accordance with Item 7.01, Regulation FD Disclosure. These exhibits shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

PROASSURANCE CORP Exhibit
EX-99.1 2 a19-11192_1ex99d1.htm EX-99.1 Exhibit 99.1   June 2019 London Investor Meetings   Table of Contents The Latest News Investments Key Themes & Topics (w/ Capital Management) 2-8 Investment Strategy 93 Management Changes 9-11 Q1 2019 Net Investment Result 94 Corporate Update / Overview 12-15 PRA Performance vs. Benchmark 95 Capital Management (Expanded) 16-21 Detailed Breakout of Investments 96-101 Operating & Financial Performance 22-30 Tax Credits 102 ROE,…
To view the full exhibit click here

About ProAssurance Corporation (NYSE:PRA)

ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers’ compensation insurance. It operates in four segments: Specialty property and casualty, which includes its professional liability business, and medical technology and life sciences business; Workers’ compensation, which includes its workers’ compensation business, which it provides for employers, groups and associations; Lloyd’s syndicate, which includes operating results from its participation in Lloyd’s Syndicate 1729, and Corporate. In addition, the Company is also a provider for Lloyd’s of London Syndicate 1729, which writes a range of property and casualty insurance, and reinsurance lines.